Cargando…
Successful therapy with rituximab in three patients with probable neurosarcoidosis
BACKGROUND: Neurosarcoidosis occurs in about 5–15% of patients with sarcoidosis. Therapy with corticosteroids is generally accepted as the first-line medication, followed by various immunomodulating and cytotoxic agents or combined therapy. However, some patients show an unsatisfactory outcome or ha...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204624/ https://www.ncbi.nlm.nih.gov/pubmed/30386436 http://dx.doi.org/10.1177/1756286418805732 |